Purified anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
30-F11_Pure_071608.jpg
BALB/c splenocytes stained with 30-F11 purified, followed by anti-rat IgG FITC
  • 30-F11_Pure_071608.jpg
    BALB/c splenocytes stained with 30-F11 purified, followed by anti-rat IgG FITC
  • 30-F11_Pure_CD45_Antibody_2_102518
    Fresh, frozen mouse spleen was stained with purified CD45 clone 30-F11 conjugated and detected with a FITC CODEX™ oligonucleotide duplex (red). Samples were counterstained with CollagenIV Cy5 (green). Data generated at Akoya Biosciences, Inc. using the CODEX™ technology.
Compare all formats
Cat # Size Price Quantity Check Availability Save
103101 50 µg 58€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
103102 500 µg 184€
Check Availability


Need larger quantities of this item?
Request Bulk Quote
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical Data Sheet (pdf)

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
IHC-F, CyTOF® - Verified
IP, CMCD, IHC, WB - Reported in the literature, not verified in house

Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Davies M, et al. 2017. PLoS Pathogens. 13(6):e1006435. PubMed
  2. Axelrod HD, et al. 2019. Mol Cancer Res. 17:356. PubMed
  3. Schneider H, et al. 2017. J Neurochem. 140:170. PubMed
  4. Shafer MER, et al. 2017. Stem Cell Reports. 1.040277778. PubMed
  5. Arnold IC, et al. 2019. PLoS Pathog. 15:e1007866. PubMed
  6. Wolf Y, et al. 2017. J Exp Med. 214:905. PubMed
  7. Hernández-Santana YE, et al. 2020. Life Sci Alliance. 3:00. PubMed
  8. Claveria-Cabello A, et al. 2020. Cancers (Basel). 12:00. PubMed
  9. Hutton C, et al. 2021. Cancer Cell. 39:1227. PubMed
  10. Blomberg E, et al. 2022. Neurooncol Adv. 4:vdac148. PubMed
  11. Murai K, et al. 2022. Nat Commun. 13:6206. PubMed
  12. Vitiello GA, et al. 2018. Clin Cancer Res. 24:972. PubMed
  13. Rothchild AC, et al. 2019. Sci Immunol. 4:eaaw6693. PubMed
  14. Widjaja AA, et al. 2019. Gastroenterology. 157:777. PubMed
  15. Reglero-Real N, et al. 2021. Immunity. :. PubMed
  16. Chamberlin T, et al. 2020. Cancer Research. 80(20):4465-4475. PubMed
  17. Li X, et al. 2020. Cell Rep. 31:107765. PubMed
  18. Kondo H, et al. 2020. J Biol Chem. 295:1658. PubMed
  19. Fernandes V, et al. 2020. PLoS Pathog. 16:e1008464. PubMed
  20. Nguyen R, et al. 2021. Cancer Immunol Immunother. 70:721. PubMed
  21. Wan Mohd Zawawi WFA, et al. 2021. Sci Rep. 11:10278. PubMed
  22. Maestro S, et al. 2021. Viruses. 13: . PubMed
  23. Moon H et al. 2017. Cell stem cell. 21(5):665-678 . PubMed
  24. Rieck M, et al. 2017. Eur J Immunol. 47:677. PubMed
  25. Ajona D, et al. 2017. Cancer Discov. 0.773611111. PubMed
  26. Goel S, et al. 2017. Nature. 548:471. PubMed
  27. Wang W, et al. 2018. Cancer Cell. 34:757. PubMed
  28. Paulo E, et al. 2018. Sci Rep. 8:11001. PubMed
  29. Arnold IC, et al. 2018. J Exp Med. 215:2055. PubMed
  30. Heinrich A, et al. 2021. Cell Rep. 37:109885. PubMed
  31. Cooper STE, et al. 2022. Int J Mol Sci. 23:. PubMed
  32. Deppermann C, et al. 2020. J Exp Med. 217:. PubMed
  33. Lee S, et al. 2020. Cell Host & Microbe. 27(6):937-949. PubMed
  34. Thulasingam S, et al. 2019. Int J Mol Sci. 20. PubMed
  35. Gao J, et al. 2017. Oncol Lett. 14:2954. PubMed
  36. Starossom SC, et al. 2019. Nat Commun. 10:217. PubMed
  37. Liu X, et al. 2020. Nature. . PubMed
  38. Altshuler A, et al. 2021. Cell Stem Cell. 28(7):1248-1261.e8. PubMed
  39. Parlanti P, et al. 2020. Exp Eye Res. 194:107998. PubMed
  40. Dertschnig S, et al. 2020. J Clin Invest. 130:1896. PubMed
  41. Gao H, et al. 2021. J Virol. :. PubMed
  42. Dienz O, et al. 2020. J Immunol. 204:1521. PubMed
  43. Karhadkar TR, et al. 2021. J Pharmacol Exp Ther. 376:106. PubMed
  44. Zabaleta N, et al. 2018. Nat Commun. 9:5454. PubMed
  45. Zhu F, et al. 2019. J Immunol. 203:2644. PubMed
  46. Li Y et al. 2019. Endocrinology. 160(4):938-946 . PubMed
  47. Murad JP, et al. 2018. Front Immunol. 1.95. PubMed
  48. Schafflick D, et al. 2020. Nat Commun. 247:11. PubMed
  49. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  50. Wang G, et al. 2021. Nat Commun. 12:5733. PubMed
  51. Quintana E, et al. 2020. Cancer Res. 80:2889. PubMed
  52. Stefanescu C, et al. 2021. Front Oncol. 11:765151. PubMed
  53. Paprckova D, et al. 2022. Front Immunol. 13:1009198. PubMed
  54. Podd B, et al. 2006. J Immunol. 176:6532. PubMed
  55. Hitchcock JR, et al. 2020. FEBS J. 287:250. PubMed
  56. McLeod RL, et al. 2018. Oncotarget. 9:34459. PubMed
  57. Sutton C, et al. 2017. Nat Commun.. 10.1038/s41467-017-02111-0. PubMed
  58. Janghorban M, et al. 2022. Cancer Res. 82:885. PubMed
  59. Jackson JW, et al. 2021. Mol Ther Oncolytics. 22:444. PubMed
  60. Mayer KA, et al. 2021. FASEB J. 35:e21217. PubMed
  61. Delgobo M, et al. 2021. Front Immunol. 12:584538. PubMed
  62. Baraibar-Churio A, et al. 2021. Life (Basel). 11:. PubMed
  63. Nam J, et al. 2021. Front Cell Neurosci. 15:640084. PubMed
  64. Park S, et al. 2021. Nat Cell Biol. 23:476. PubMed
  65. Rhee S, et al. 2018. Nat Commun. 9:368. PubMed
  66. Finn J et al. 2019. Cell reports. 26(11):2942-2954 . PubMed
  67. Nolin JD, et al. 2017. JCI Insight. 2:e94929. PubMed
  68. Fiege JK, et al. 2019. PLoS Pathog. 15:e1008077. PubMed
  69. Silvestre-Roig C, et al. 2019. Nature. 569:236. PubMed
  70. Melchor SJ, et al. 2020. Sci Rep. 10:15724. PubMed
  71. Hagan AS, et al. 2020. Development. 147:00:00. PubMed
  72. O'Dea KP, et al. 2020. J Extracell Vesicles. 9:1706708. PubMed
  73. Baluk P, et al. 2020. Am J Pathol. 190:2355. PubMed
  74. Suzuki Y, et al. 2021. FEBS Open Bio. 11:2619. PubMed
  75. Gil-Melgosa L, et al. 2021. Biomedicines. 10:. PubMed
  76. Seelige R, et al. 2018. Sci Rep. 8:13670. PubMed
  77. Yoshihara S, et al. 2019. Front Immunol. 0.545833333. PubMed
  78. Mrdjen D et al. 2018. Immunity. 48(2):380-395 . PubMed
  79. Karhadkar TR, et al. 2021. PLoS One. 16:e0245924. PubMed
  80. Gereke M, et al. 2012. J Vis Exp. 70: 4322. PubMed
  81. He LD, et al. 2021. EMBO Rep. 22:e52196. PubMed
  82. Yim AKY, et al. 2022. Nat Neurosci. 25:238. PubMed
  83. Singh PP, et al. 2021. Ocul Surf. 21:271. PubMed
  84. Cassidy BR, et al. 2020. J Neuroinflammation. 17:259. PubMed
  85. Peralta Ramos JM, et al. 2017. Front Immunol. 1.490277778. PubMed
  86. Ito S, et al. 2020. PLoS One. 15:e0229888. PubMed
  87. Latasa M, et al. 2010. PLoS One. 5:e15690. PubMed
  88. Fu H, et al. 2020. Front Immunol. 11:595813. PubMed
  89. Progatzky F, et al. 2021. Nature. 599:125. PubMed
  90. Bruno KA, et al. 2021. Int J Mol Sci. 22:. PubMed
  91. Crawford LB, et al. 2020. Microorganisms. 8:. PubMed
  92. Liu H, et al. 2020. J Immunol. 205:1207. PubMed
  93. Shokirova H, et al. 2021. Sci Rep. 11:8647. PubMed
  94. Brown IK, et al. 2021. PLoS Pathog. 17:e1009602. PubMed
  95. Qiu X, et al. 2018. Lab Chip. 18:2776. PubMed
  96. Tsubaki T, et al. 2018. Oncotarget. 9:11209. PubMed
  97. Hoves S, et al. 2018. J Exp Med. 215:859. PubMed
  98. Vu LT, et al. 2019. J Extracell Vesicles. 8:1599680. PubMed
  99. Jones KB et al. 2018. Cell stem cell. 24(1):183-192 . PubMed
  100. Kenswil KJG, et al. 2021. Cell Stem Cell. 28(4):653-670.e11. PubMed
  101. Zareie P, et al. 2017. J Neuroinflammation. 0.630555556. PubMed
  102. Zhong L, et al. 2022. JCI Insight. 7:. PubMed
  103. Murai K et al. 2018. Cell stem cell. 23(5):687-699 . PubMed
  104. Morita S et al. 2017. Cell metabolism. 25(4):883-897 . PubMed
  105. Sheppard S, et al. 2018. Front Immunol. 1.630555556. PubMed
  106. Davies CL, et al. 2019. Front Immunol. 10:1048. PubMed
  107. Paharik AE, et al. 2017. Cell Host Microbe. 22:746. PubMed
  108. Nikolaou K, et al. 2014. EMBO J. 34:430. PubMed
  109. Johnson SA, et al. 2021. Eur J Immunol. 51:3228. PubMed
  110. Schuler CF, et al. 2020. Allergy. 75:2279. PubMed
  111. Yoon S, et al. 2020. Antioxidants (Basel). 10:. PubMed
  112. Hashimoto M, et al. 2021. J Neurochem. 156:834. PubMed
  113. Tao H, et al. 2021. Front Immunol. 12:623280. PubMed
  114. Scur M, et al. 2022. Nat Commun. 13:7272. PubMed
  115. Matsuo K, et al. 2018. J Invest Dermatol. 138:1764. PubMed
  116. Bar O, et al. 2020. Fluids Barriers CNS. 17:27. PubMed
  117. Langer V, et al. 2019. J Clin Invest. 129:4691. PubMed
  118. Poulos MG, et al. 2017. J Clin Invest. 127:4163. PubMed
  119. Janela B, et al. 2019. Immunity. 50:1069. PubMed
  120. Karhadkar TR, et al. 2020. bioRxiv. . PubMed
  121. Chen Q, et al. 2021. STAR Protocols. 2(1):100241. PubMed
  122. Lopes N, et al. 2021. Nat Immunol. 22:179. PubMed
  123. Perdigoto AL, et al. 2022. JCI Insight. 7:. PubMed
  124. Ejima R, et al. 2021. Nutrients. 13:. PubMed
  125. Hu CF, et al. 2021. Front Immunol. 12:638381. PubMed
  126. Baluk P, et al. 2018. Methods Mol Biol. 1846:161. PubMed
  127. Fino KK, et al. 2017. Sci Rep. 5.334722222. PubMed
  128. Mensurado S, et al. 2018. PLoS Biol. 16:e2004990. PubMed
  129. Prizant H, et al. 2021. Cell Reports. 36(6):109523. PubMed
  130. Yu W, et al. 2020. J Clin Invest. . PubMed
  131. Geng T, et al. 2021. J Infect Dis. 223:2186. PubMed
  132. Ishigaki K, et al. 2021. Sci Rep. 11:13958. PubMed
  133. Tsukui H, et al. 2020. BMC Cancer. 20:411. PubMed
  134. Somasundaram R, et al. 2021. Blood. 137:3037. PubMed
  135. Kim D, et al. 2019. Immune Netw. 19:e32. PubMed
  136. Chen X, et al. 2019. Methods Mol Biol. 2048:131. PubMed
  137. Nagatake T, et al. 2018. J Allergy Clin Immunol. 142:470. PubMed
  138. Moon H, et al. 2019. Nat Commun. 10:2225. PubMed
  139. Wang Z, et al. 2021. Drug Discov Ther. 14:304. PubMed
  140. Levy BD, et al. 2020. J Allergy Clin Immunol. 145:335. PubMed
  141. Seo SU, et al. 2021. Front Immunol. 12:697162. PubMed
  142. Roussey JA, et al. 2017. J Immunol. 199:3535. PubMed
  143. Tamburini BAJ, et al. 2019. Front Immunol. 10:1036. PubMed
  144. Cha J, et al. 2015. J Biol Chem. 290:15337. PubMed
  145. Mori Y, et al. 2021. Diabetes and Vascular Disease Research. 18(3):14791641211027324. PubMed
  146. Dora D, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:1617. PubMed
  147. Fahy N, et al. 2021. Front Immunol. 12:715267. PubMed
  148. Brownlie D, et al. 2021. J Immunother Cancer. 9:. PubMed
  149. Rincón E, et al. 2017. Oncotarget. 8:45415. PubMed
  150. Deng W et al. 2019. Cell reports. 27(6):1755-1768 . PubMed
  151. Van Der Zande HJP, et al. 2021. FASEB J. 35:e21331. PubMed
  152. Penny HL, et al. 2021. Int J Mol Sci. 22:. PubMed
  153. Chao Y, et al. 2020. Sci Adv. 6:eaaz4204. PubMed
  154. Lee YJ, et al. 2018. Front Microbiol. 9:83. PubMed
  155. Heinrich A, et al. 2020. Cell Rep. 31:107513. PubMed
  156. DeFalco T, et al. 2014. Proc Natl Acad Sci U S A. 111:2384. PubMed
  157. Li Y, et al. 2020. Elife. 9:00. PubMed
  158. Parodi B, et al. 2021. Front Immunol. 12:655212. PubMed
  159. Mohrin M, et al. 2021. Aging Cell. 20:e13313. PubMed
  160. Cané S, et al. 2021. J Immunother Cancer. 9:. PubMed
  161. Udumula MP, et al. 2021. Mol Metab. 53:101272. PubMed
  162. Diao J, et al. 2018. J Immunol. 201:1306. PubMed
  163. Pushalkar S, et al. 2018. Cancer Discov. 0.613194444. PubMed
  164. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  165. Stokes KL, et al. 2019. Oncogenesis. 8:24. PubMed
  166. Krenzlin H, et al. 2019. J Clin Invest. 130:1671. PubMed
  167. Winter C, et al. 2018. Cell Metab. 28:175. PubMed
  168. Huppé CA, et al. 2018. Mucosal Immunol. 0.536111111. PubMed
  169. Aikawa S, et al. 2020. Cell Death Differ. 1489:27. PubMed
  170. Van Winkle JA, et al. 2020. J Virol. 94:. PubMed
  171. Maier B, et al. 2020. Nature. 580:257. PubMed
  172. Wang J, et al. 2021. Am J Cancer Res. 11:2005. PubMed
  173. Bernard S, et al. 2018. J Mammary Gland Biol Neoplasia. 23:249. PubMed
  174. Leist SR, et al. 2019. PLoS One. 14:e0220126. PubMed
  175. Zhang J, et al. 2019. Onco Targets Ther. 12:4985. PubMed
  176. Kästle M, et al. 2020. Cell Commun Signal. 183:18. PubMed
  177. Hassel C, et al. 2021. Front Immunol. 12:754661. PubMed
  178. Obst J, et al. 2020. Front Immunol. 11:579000. PubMed
  179. Dubik M, et al. 2021. Front Neurosci. 15:682451. PubMed
  180. Shao Y, et al. 2017. Onco Targets Ther. 10:2675. PubMed
  181. He X, et al. 2017. Cancer Biol Ther. 0.815277778. PubMed
  182. Haber AL, et al. 2017. Nature. 551:333. PubMed
  183. Emrick JJ, et al. 2018. Proc Natl Acad Sci U S A. 115:E12091. PubMed
  184. Seehus CR, et al. 2017. Nat Commun. 8:1900. PubMed
  185. Cédile O, Wlodarczyk A, and Owens T 2017. APMIS.. 10.1111/apm.12740. PubMed
  186. Wilke JBH, et al. 2021. Mol Psychiatry. 26:7746. PubMed
  187. Umeda M, et al. 2021. Proc Natl Acad Sci U S A. 118:. PubMed
  188. Kästele V, et al. 2021. Mucosal Immunol. 14:717. PubMed
RRID
AB_312966 (BioLegend Cat. No. 103101)
AB_312967 (BioLegend Cat. No. 103102)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC, IHC-F, CyTOF®, IP, CMCD, IHC, WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC, SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC, ICC, IHC, 3D IHC, SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC, SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F, FC, 3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC, SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC, CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC, CyTOF®, IP, CMCD, IHC, WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Go To Top Version: 3    Revision Date: 10/25/2018

For research use only. Not for diagnostic use. Not for resale. BioLegend will not be held responsible for patent infringement or other violations that may occur with the use of our products.

 

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/ordering#license). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products, reverse engineer functionally similar materials, or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.

 

BioLegend Inc., 8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

  • APC anti-mouse CD45

  • Biotin anti-mouse CD45

  • FITC anti-mouse CD45

  • PE anti-mouse CD45

  • PE/Cyanine5 anti-mouse CD45

  • Purified anti-mouse CD45

  • PE/Cyanine7 anti-mouse CD45

  • APC/Cyanine7 anti-mouse CD45

  • Alexa Fluor® 488 anti-mouse CD45

  • Alexa Fluor® 647 anti-mouse CD45

  • Pacific Blue™ anti-mouse CD45

  • Alexa Fluor® 700 anti-mouse CD45

  • PerCP/Cyanine5.5 anti-mouse CD45

  • PerCP anti-mouse CD45

  • Alexa Fluor® 594 anti-mouse CD45

  • Brilliant Violet 421™ anti-mouse CD45

  • Brilliant Violet 570™ anti-mouse CD45

  • Brilliant Violet 510™ anti-mouse CD45

  • Brilliant Violet 605™ anti-mouse CD45

  • Purified anti-mouse CD45 (Maxpar® Ready)

  • PE/Dazzle™ 594 anti-mouse CD45

  • Brilliant Violet 711™ anti-mouse CD45

  • Brilliant Violet 785™ anti-mouse CD45

  • Brilliant Violet 650™ anti-mouse CD45

  • APC/Fire™ 750 anti-mouse CD45

  • Brilliant Violet 750™ anti-mouse CD45

  • TotalSeq™-A0096 anti-mouse CD45

  • TotalSeq™-B0096 anti-mouse CD45

  • Ultra-LEAF™ Purified anti-mouse CD45

  • Spark Blue™ 550 anti-mouse CD45

  • Spark NIR™ 685 anti-mouse CD45

  • TotalSeq™-C0096 anti-mouse CD45

  • Spark YG™ 570 anti-mouse CD45

  • PE/Fire™ 640 anti-mouse CD45

  • APC/Fire™ 810 anti-mouse CD45

  • PE/Fire™ 700 anti-mouse CD45

  • Spark Violet™ 538 anti-mouse CD45

  • Spark YG™ 593 anti-mouse CD45

  • Spark Blue™ 574 anti-mouse CD45 Antibody

ProductsHere

Login / Register
Remember me
Forgot your password? Reset password?
Create an Account